Abstract:Unlike normal cells, cancer cells frequently exhibit supernumerary centrosomes, leading to formation of multipolar spindles that can trigger cell death. Nevertheless, cancer cells with supernumerary centrosomes escape the deadly consequences of unequal segregation of genomic material by coalescing their centrosomes into two poles. This unique trait of cancer cells presents a promising target for cancer therapy, focusing on selectively attacking cells with supernumerary centrosomes. Nek2A is a kinase involved in mitotic regulation, including the centrosome cycle, where it phosphorylates linker proteins to separate centrosomes. In this study, we investigated if Nek2A also prevents clustering of supernumerary centrosomes, akin to its separation function. Reduction of Nek2A activity, achieved through knockout, silencing, or inhibition, promotes centrosome clustering, whereas its overexpression results in inhibition of clustering. Significantly, prevention of centrosome clustering induces cell death, but only in cancer cells with supernumerary centrosomes, both in vitro and in vivo. Notably, none of the known centrosomal (e.g., CNAP1, Rootletin, Gas2L1) or non-centrosomal (e.g., TRF1, HEC1) Nek2A targets were implicated in this machinery. Additionally, Nek2A operated via a pathway distinct from other proteins involved in centrosome clustering mechanisms, like HSET and NuMA. Through TurboID proximity labeling analysis, we identified novel proteins associated with the centrosome or microtubules, expanding the known interaction partners of Nek2A. KIF2C, in particular, emerged as a novel interactor, confirmed through coimmunoprecipitation and localization analysis. The silencing of KIF2C diminished the impact of Nek2A on centrosome clustering and rescued cell viability. Additionally, elevated Nek2A levels were indicative of better patient outcomes, specifically in those predicted to have excess centrosomes. Therefore, while Nek2A is a proposed target, its use must be specifically adapted to the broader cellular context, especially considering centrosome amplification. Discovering partners such as KIF2C offers fresh insights into cancer biology and new possibilities for targeted treatment.

Nek2A destruction marks APC/C activation at the prophase-to-prometaphase transition by spindle-checkpoint-restricted Cdc20

APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box

NEK2A Interacts with MAD1 and Possibly Functions As a Novel Integrator of the Spindle Checkpoint Signaling.

The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability

Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction

Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression

The Mitotic Checkpoint Complex controls the association of Cdc20 regulatory protein with the ubiquitin ligase APC/C in mitosis

A dual‐kinase mechanism controls APC phosphorylation and dissociation from microtubules during mitosis

The HECT Type Ubiquitin Ligase NEDL2 is Degraded by Anaphase-promoting Complex/Cyclosome (Apc/c)-Cdh1, and Its Tight Regulation Maintains the Metaphase to Anaphase Transition

Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts.

Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells

Nek2A kinase regulates the localization of numatrin to centrosome in mitosis.

The Bub1–Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation

Structural Analysis of Human Cdc20 Supports Multisite Degron Recognition by APC/C

Oncogenic Adenomatous Polyposis Coli Mutants Impair the Mitotic Checkpoint Through Direct Interaction with Mad2

NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes

NuSAP is Degraded by APC/C–Cdh1 and Its Overexpression Results in Mitotic Arrest Dependent of Its Microtubules' Affinity

Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.

Protein Phosphatase-1α Regulates Centrosome Splitting Through Nek2

The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells